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Abstract
Background
Preterm birth is a major risk factor for neurodevelopmental delays and disorders. This study
aimed to identify genomic biomarkers of intrauterine inflammation in umbilical cord tissue in
preterm neonates that predict cognitive impairment at 10 years of age.
Study design
Genome-wide messenger RNA (mRNA) levels from umbilical cord tissue were obtained
from 43 neonates born before 28 weeks of gestation. Genes that were differentially
expressed across four indicators of intrauterine inflammation were identified and their func-
tions examined. Exact logistic regression was used to test whether expression levels in
umbilical cord tissue predicted neurocognitive function at 10 years of age.
Results
Placental indicators of inflammation were associated with changes in the mRNA expression
of 445 genes in umbilical cord tissue. Transcripts with decreased expression showed signifi-
cant enrichment for biological signaling processes related to neuronal development and
growth. The altered expression of six genes was found to predict neurocognitive impairment
when children were 10 years old These genes include two that encode for proteins involved
in neuronal development.
Conclusion
Prenatal intrauterine inflammation is associated with altered gene expression in umbilical
cord tissue. A set of six of the differentially expressed genes predict cognitive impairment
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later in life, suggesting that the fetal environment is associated with significant adverse
effects on neurodevelopment that persist into later childhood.
Introduction
Preterm birth, defined as delivery at< 37 completed weeks gestation, is currently the leading
cause of neonatal morbidity and mortality in the United States [1]. Individuals born prema-
turely are at increased risk for other adverse health outcomes, and those born at less than 28
weeks gestation are at particularly high risk [2]. Perhaps most important are adverse neurode-
velopmental outcomes, which affect an estimated 1 million preterm infants born each year [3].
Preterm birth is thought to be caused by the pathological induction of certain components
of the normal parturition process resulting from a combination of environmental, genetic, and
behavioral factors [4,5]. Many identified risk factors have the potential to promote inflamma-
tory processes [6]. Indicators of intrauterine inflammation are present in as many as 40–70%
of preterm births, versus only 1–13% of full term births [7]. These data support the hypothesis
that risk of preterm birth is increased by pathological, environmental, and/or genetic factors
that contribute to delivery-inducing inflammation [4,8]. Among preterm infants, biomarkers
of prenatal inflammation, including inflammatory cytokines in amniotic fluid [9], placental
histologic findings [10–12], and inflammation-related proteins in neonatal blood [13–17], are
associated with a range of neurodevelopmental impairments [18].
A fetal inflammatory response (FIR) is associated with increased expression of a broad
array of genes related to neurodevelopment [19]. In the present study, we aimed to identify
whether genomic signaling changes in umbilical cord tissue were associated with a suite of
four histologic markers of prenatal inflammation in a subset of infants from the Extremely
Low Gestational Age Newborns (ELGAN) cohort. We hypothesized that some of these geno-
mic changes would be predictive of neurocognitive function at 10 years of age and could pro-
vide novel predictive biomarkers of neurocognitive impairment in preterm infants.
Materials and methods
The ELGAN cohort
The ELGAN cohort was established to identify risk factors for neurodevelopmental impair-
ments in extremely low gestational age newborns. Between 2002–2004, 1506 infants were
enrolled in the study, and in 1410 cases (94% of the cohort) placentas were collected for patho-
logical examination. Placentas were collected at delivery and flash frozen to -70 C. Placentas
were examined both grossly and histologically for many parameters, including a subset of
intrauterine inflammation markers. The larger ELGAN cohort is described in detail elsewhere
[20,21].
RNA isolation and gene expression assessment
The data in this study were generated by Cohen et al. from isolated total RNA from the umbili-
cal cord tissue homogenates collected from infants born between 23 and 28 weeks gestation at
Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, or Wake-Forest Med-
ical Center between April 1, 2004 and August 31, 2004. RNA was extracted using the Qiagen
RNeasy Mini Kit, as described elsewhere [22]. Thirteen samples had insufficient total RNA
(< 7 μg) for hybridization and five infants died before 36 weeks postmenstrual age. These 18
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infants were excluded from further analysis. Total RNA from the 54 remaining ELGAN sub-
jects were hybridized to the Affymetrix Human Genome U133 Plus 2.0 Array, which assesses
gene expression levels across 54,675 probes. All expression data are available at the National
Center for Biotechnology Information’s Gene Expression Omnibus repository (GSE8586)
[22]. The data were further processed previously, applying quality control assessments to all 54
samples [19]. Six samples that failed these measures were excluded from further analysis [19].
Data were normalized into Affymetrix probesets using fRMA [19]. An additional five subjects
were excluded from analysis due to missing clinical information about intrauterine inflamma-
tion markers from the umbilical cord tissue. Probes without annotations to Entrez gene identi-
fiers were removed and only the probeset with the largest inter quartile range per Entrez gene
was kept. The final data set consisted of measures of gene expression across 20,155 genes for
n = 43 subjects [19] (S1 Table).
Cognitive assessment at 10 years of age
When study participants were 10 years of age, general cognitive ability (or IQ) was assessed
with the School-Age Differential Ability Scales–II (DAS-II) Verbal and Nonverbal Reasoning
scales [23]. Attention and executive function were assessed with the DAS-II and the NEPSY-II
[24]. DAS-II Recall of Digits Backward and Recall of Sequential Order measured verbal work-
ing memory. NEPSY-II Auditory Attention and Auditory Response Set evaluated auditory
attention, set switching and inhibition. NEPSY-II Inhibition and Inhibition Switching assessed
simple inhibition and inhibition in the context of set shifting, respectively. NEPSY-II Animal
Sorting measured concept generation and mental flexibility. As a comprehensive measure of
cognitive and executive function, we used latent profile analysis (LPA) to identify study partic-
ipants with similar distinctive profiles on measures of cognitive and executive functioning.
With this approach, four subgroups were identified, corresponding to functioning that was
normal (LPA score = 1; 34% of ELGAN cohort), low-normal (LPA score = 2; 41%), moderately
impaired (LPA score = 3; 17%), and severely impaired (LPA score = 4; 8%) [25,26].
Relating gene expression to prenatal inflammation measures
Four markers of intrauterine inflammation were selected to test for associations with gene
expression: inflammation of the chorionic plate, moderate or severe chorioamnionitis, neutro-
philic infiltration of the fetal vessels in the chorionic plate, umbilical cord inflammation [27].
Using ANCOVA analysis, these binary measures were assessed separately. Potential confound-
ers were included in the ANCOVA analysis for each placental histologic marker only if they
displayed different means (2-sided student t-test p-value < 0.20) between subjects with that
placental inflammation marker and without that placental marker. Variables tested but that
displayed no mean difference in any of the four histologic markers of placenta inflammation
included maternal age, maternal race, maternal BMI, maternal education level and infant sex.
Exposure to smoke (active or passive) during pregnancy was included in the analysis for chor-
ioamnionitis and neutrophilic infiltration of the fetal vessels, and gestational age was also
included in the analysis for neutrophilic infiltration of the fetal vessels. In order to control for
multiple tests, false discovery rate (FDR) q-values were calculated. Significance was defined as
FDR q-value < 0.05 and an absolute fold change |2.0|.
Network analysis of genes associated with prenatal inflammation
measures
In order to examine the higher-level biological functions and processes related to genes
changed in association with four markers of prenatal intrauterine inflammation, functional
Genomics and neuroimpairment
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relationships were assessed among these genes using Ingenuity Network Analysis (IPA) (Inge-
nuity Systems1, Redwood City, CA, USA) and STRING v10.0 [28,29]. Network analyses were
stratified by directionality of gene expression associations. Canonical pathways from IPA and
PFAM protein domains enriched among these gene sets were analyzed and reported.
Logistic regression of genomic markers of inflammation to later life
neurological score
We tested whether the expression levels of genes associated with one or more intrauterine
inflammation marker predicted later life neurocognitive function using exact logistic regres-
sion analysis. Exact logistic regression was used due to the small subset of subjects for whom
LPA score measured (n = 22). The dependent variable was the child’s LPA score at age 10, with
expression levels predicting the binary outcome of (i) no or low impairment (LPA score = 1 or
2, n = 17) or (ii) moderate or severe impairment (LPA score = 3 or 4, n = 5). As potential con-
founders had been controlled for in the first step of this analysis, the model was run with gene
expression as the sole predictor variable. Significance was defined as an exact p-value < 0.05,
and exact beta estimates, exact parameter-likelihood odds ratios and 95% confidence intervals
for odds ratios are reported.
Results
Characteristics of the study cohort
Maternal and infant demographic and birth clinical data are presented in Table 1 for the subset
of the ELGAN subjects with gene expression data used in this study (n = 43). In these infants,
the majority of mothers were white and reported no smoking during pregnancy. The mean
week of delivery was 26.1, and approximately two-thirds of the infants were male (Table 1).
The demographic characteristics in this subset of ELGAN infants were similar to those
reported for all ELGAN subjects [21], with the exception of a higher proportion of males in
this cohort. We calculated the prevalence of four histological markers of prenatal intrauterine
inflammation: inflammation of the chorionic plate, neutrophilic infiltration of the fetal vessels
in the chorionic plate, and umbilical cord inflammation were all present in approximately 25%
of the study subjects, while moderate or severe chorioamnionitis was present in approximately
50% of the study subjects (Table 1). The occurrence of these four histologic markers of inflam-
mation were consistent with those reported in larger study (n = 947) of the ELGAN cohort
[20].
Markers of prenatal inflammation are associated with umbilical cord
gene expression
A comparison of mRNA expression between subjects with or without each of the four markers
of intrauterine inflammation identified 445 unique genes (S1 Table). Among these 445 genes,
334 (75.1%) were increased in expression in association with at least one histological marker of
intrauterine inflammation, and 111 (24.9%) were decreased in expression in association with
at least one histological marker of intrauterine inflammation (Fig 1). All genes demonstrated
remarkable consistency in the directionality of expression when associated with more than
one marker of intrauterine inflammation (Fig 1). Inflammation of the chorionic plate was
associated with the expression levels of 255 genes; moderate or severe chorioamnionitis was
associated with the expression levels of 396 genes; neutrophilic infiltration of the fetal vessels
in the chorionic plate was associated with the expression levels of 365 genes; and umbilical
cord inflammation was associated with the expression levels of 323 genes. In addition, 221
Genomics and neuroimpairment
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Table 1. Maternal and child characteristics. Data are number of study participants (percent) except where indicated.
Characteristic N = 1410 ELGAN Subjects N = 43 ELGAN Subjects N = 22 ELGAN Subjects
Maternal Age at Delivery in years (median; range in parenthesis) 28.6
(13.2–47.3)
32.1
(15.8–43.2)
34
(19.4–43.2)
Maternal Race
White 819 (58.1%) 26 (60.5%) 18 (81.8%)
African-American 397 (28.2%) 9 (20.9%) 4 (18.2%)
Other 178 (12.6%) 7 (16.3%) 0 (0%)
Unknown 16 (1.1%) 1 (2.3%) 0 (0%)
Pre-pregnancy BMI (kg/m2) (median; range in parenthesis) 23.9
(13.2–72.1)
23.1
(18.1–46.5)
22.5
(19.1–46.5)
Public Health Insurance
No 785 (55.7%) 31 (72.1%) 19 (86.3%)
Yes 558 (39.6%) 12 (27.9%) 3 (13.6%)
Unknown 67 (4.8%)
Education
< = 12 years 224 (15.9) 10 (23.3%) 3 (13.6%)
12–15 years 681 (48.3%) 12 (27.9%) 7 (31.8%)
16+ years 404 (28.7%) 20 (46.5%) 11 (50.0%)
Unknown 101 (7.2%) 1 (2.3%) 1 (4.5%)
Infertility Treatment
No 1063 (75.4%) 31 (72.1%) 14 (63.6%)
Yes 264 (18.7%) 12 (27.9%) 8 (36.4%)
Unknown 83 (5.9%)
Smoking during Pregnancy
No 1133 (80.4%) 40 (93.0%) 20 (90.9%)
Yes 199 (14.1%) 3 (7.0%) 2 (9.1%)
Unknown 78 (5.5%)
Infant Sex
Male 752 (46.7%) 27 (62.8%) 14 (63.6%)
Female 658 (46.7%) 16 (37.2%) 6 (27.3%)
Birth and Later Life Outcomes
Gestational Age (weeks)
Median (range) 28.6
(13.2–47.3)
27
(23–27)
27
(23–27)
23–24 weeks 387 (27.5%) 6 (14.0%) 2 (9.1%)
25–26 weeks 618 (43.8%) 14 (32.6%) 8 (36.4%)
27 weeks 405 (28.7%) 23 (53.5%) 12 (54.5%)
Birth weight (g) (median; range in parenthesis) 790
(280–1528)
929.7, 952
(550–1360)
889.5
(550–1360)
Inflammation of the chorionic plate (Stage: 3 and Severity: 3)
No 1118 (79.3%) 32 (74.4%) 16 (72.7%)
Yes 265 (18.8) 11 (25.6%) 6 (27.3%)
Unknown 27 (1.9%)
Moderate/Severe Chorioamnionitis
No 879 (62.3%) 23 (53.5%) 13 (59.1%)
Yes 505 (35.8%) 20 (46.5%) 9 (40.9%)
Unknown 26 (1.8%)
Neutrophilic infiltration of fetal vessels in the chorionic plate
No 1034 (73.3%) 29 (67.4%) 15 (68.2%)
(Continued )
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genes were associated with the same directionality across all four intrauterine inflammation
markers. Specifically, 168 of these 221 genes (76.0%) were increased in expression in associa-
tion with the four intrauterine inflammation markers, 53 of these 221 (24.0%) genes were
decreased in expression (S1 Table).
Umbilical cord tissue gene expression profiles are enriched for
inflammation and neuronal development processes
Systems level analysis was used to characterize the canonical pathways and protein domains
enriched within the 334 genes with increased expression in association with one or more histo-
logical marker of intrauterine inflammation and the 111 genes with decreased expression in
association with one or more histological marker of intrauterine inflammation. Notably, dif-
ferences in functional signaling between the genes with increased and decreased expression
were observed (Table 2). Specifically, the most significant canonical pathway enriched among
the genes with increased expression was granulocyte adhesion and diapedesis, and the other
top pathways were also associated with inflammation signaling (Table 2). In contrast, the most
significant canonical pathways among the genes with decreased expression included gap junc-
tion signaling and dopamine-DARPP32 feedback in cAMP signaling, both of which are
known to play important roles in early neuronal development (Table 2) [30–32]. Similarly, the
protein domains that were significantly enriched among the genes with increased expression
in association with one or more histological marker of intrauterine inflammation were small
cytokines, metallothionein, and S-100/ ICaBP type calcium binding domain. Proteins contain-
ing all of these domains have been demonstrated to play a role in placental inflammation [33–
35]. Interestingly, elevated levels of interleukin-8 (IL-8) in cord blood have been previously
associated with a higher incidence with brain injury in preterm infants with placental inflam-
mation [35]. Among genes with decreased expression, immunoglobulin I-set protein domains,
which are known to function in nervous system development, were found to be significantly
enriched [36]. Specifically, among the genes associated with a marker of intrauterine
Table 1. (Continued)
Characteristic N = 1410 ELGAN Subjects N = 43 ELGAN Subjects N = 22 ELGAN Subjects
Yes 340 (24.1%) 14 (32.6%) 7 (31.8%)
Unknown 36 (2.6%)
Umbilical cord inflammation (grade 3–5)
No 1136 (80.1%) 31 (72.1%) 16 (72.7%)
Yes 216 (15.3%) 12 (27.9%) 6 (27.3%)
Unknown 58 (4.1%)
LPA Score
1 282 (20.0%) 13 (30.2%) 13 (59.1%)
2 337 (23.9%) 4 (9.3%) 4 (18.2%)
3 134 (9.5%) 4 (9.3%) 4 (18.2%)
4 66 (4.7) 1 (2.3%) 1 (4.5%)
Unknown 591 (41.9%) 21 (48.8%) 0 (0%)
Maternal demographic data, pregnancy characteristics, and data on birth and later in life outcomes are presented for the entire ELGAN sample for which
placentas were collected (N = 1410), as well as the N = 43 and N = 22 ELGAN subjects used in this analysis. Data are presented as the number (%) of
subjects in the cohort unless otherwise noted. For each of the four histological markers of intrauterine inflammation, there was no significant difference in
maternal age, maternal race, maternal BMI, maternal education level and infant sex between subjects with and without each marker (Student’s 2-sided t-
test p-value > 0.20).
https://doi.org/10.1371/journal.pone.0176953.t001
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inflammation that encode for a protein with an immunoglobulin I-set protein domain and
that have been previously indicated in neurodevelopment were contactin 1 (CNTN1), neuronal
growth regulator 1 (NEGR1), neurotrophic receptor tyrosine kinase 3 (NTRK3), and receptor
tyrosine kinase like orphan receptor 1 (ROR1) [37–40].
Genomic changes in umbilical cord tissue are related to neurocognitive
function
In exact logistic regression models testing all 445 genes, expression levels of 6 genes altered in
association with one or more histological marker of prenatal intrauterine inflammation also
predicted neurocognitive impairment later in life (Fig 2, S2 Table). Increased expression levels
of chromosome 10 open reading frame 54 (C10orf54, p = 3.64e-2) and glutathione peroxidase
3 (GPX3, p = 4.53e-2) predicted greater neurocognitive impairment later in life and were also
increased in association with at least one marker of prenatal intrauterine inflammation (Fig 2).
Decreased expression levels of cysteine rich secretory protein LCCL domain containing 1
(CRISPLD1, p = 4.06e-2), extracellular matrix protein 2 (ECM2, p = 2.86e-2), olfactomedin like
1 (OLFML1, p-value = 3.36e-2), and paraneoplastic Ma antigen family like 1 (PNMAL1, p-
Fig 1. Heatmap of 445 genes that displayed significant differential expression values across one or more markers of intrauterine
inflammation in n = 43 subjects. The absolute fold change (cases/controls) is displayed for each gene significantly associated with each
marker of intrauterine inflammation. Red indicates increased expression in association with a marker of intrauterine inflammation and blue
indicates decreased expression in association with a marker of intrauterine inflammation. Rows (genes) were organized by unsupervised
hierarchical clustering Euclidean dissimilarity with average linkage. Significance was defined as FDR q-value < 0.05 and fold change |2.0|.
https://doi.org/10.1371/journal.pone.0176953.g001
Genomics and neuroimpairment
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value = 4.89e-2) predicted more severe neurocognitive impairment and were also decreased in
association with at least one marker of prenatal intrauterine inflammation (Fig 2). CRISPLD1
and ECM2 have been suggested to play roles in neuronal development [41,42].
Discussion
In this study, we have demonstrated evidence of genomic signaling changes in the umbilical
cord tissue of extremely preterm infants that are associated with multiple markers of intrauter-
ine inflammation. Two interesting patterns of gene expression were observed; inflammation-
associated genes displayed increased expression in the cord, while among the genes that dis-
played decreased expression, several were related to neurodevelopment. Expression levels of six
genes altered in umbilical cord tissue in association with one or more intrauterine inflamma-
tion marker significantly predict the risk of neurocognitive impairment later in life. In support
of our data, several of these genes whose decreased expression predicted more severe cognitive
impairment have been previously implicated in neuronal development. Our results indicate
that genomic changes observable at parturition in the umbilical cord tissue of extremely low
gestational age newborns are associated with neurocognitive function later in life.
Preterm newborns are at increased risk for numerous adverse health effects, many of which
are related to prenatal intrauterine inflammation, including neurodevelopmental impairment
Table 2. Top canonical pathways and protein domains enriched among the 445 genes associated with intrauterine inflammation markers.
IPA Canonical
Pathways
p-
value
Associated Genes PFAM Protein Domains p-
value
Associated Genes
Genes with
Increased
Expression
Levels
Granulocyte Adhesion
and Diapedesis
1.58e-
23
IL1RL1, ITGAM, MMP9, SELL, CSF3R,
CCL20, IL1R2, ITGB2, SELE, FPR1,
VCAM1, CXCL6, CXCR4, IL1RN, IL1R1,
C5AR1, CXCL1, CXCL5, CCL5, IL1B,
TNFRSF1B, CXCL2, PPBP, CXCL8,
TNFRSF11B, CCL2, SELPLG, MMP10,
CXCL3, CSF3, ICAM1
Small cytokines
(intecrine/ chemokine),
interleukin-8 like
1.13e-
4
CCL2, CCL20,
CCL5, CXCL1,
CXCL2, CXCL5, IL8
Hepatic Fibrosis /
Hepatic Stellate Cell
Activation
1.58e-
16
IL1RL1, MMP9, IL1R2, IL6, VCAM1,
IL10RA, IFNGR1, IL1R1, FLT1, IGFBP3,
CCL5, IL1B, VEGFA, PDGFRA, CD14,
TNFRSF1B, CXCL8, NFKB2,
TNFRSF11B, COL11A1, CCL2, CXCL3,
TIMP1, SERPINE1, ICAM1
Metallothionein 4.27e-
2
MT1H, MT1X,
MT2A
Atherosclerosis
Signaling
7.94e-
16
CCR2, S100A8, IL1B, MMP9, ITGB2,
SELE, IL6, VCAM1, CXCL8, ALOX5,
NFKB2, LYZ, CXCR4, IL1RN, CCL2,
SELPLG, SERPINA1, F3, PLBD1,
ICAM1, PLA2G2A
S-100/ ICaBP type
calcium binding domain
4.27e-
2
S100A4, S100A8,
S100A9, S100P
Genes with
Decreased
Expression
Levels
Gap Junction
Signaling
2.04e-
5
CAV1, GUCY1A2, GUCY1A3, GAB1,
PLCE1, PRKAG2, PLCL1
Immunoglobulin I-set
domain
1.83e-
3
CNTN1, NEGR1,
NTRK3, OPCML,
ROR1Cellular Effects of
Sildenafil (Viagra)
4.57e-
5
MYH3, GUCY1A2, PLCE1, GUCY1A3,
PRKAG2, PLCL1
Dopamine-DARPP32
Feedback in cAMP
Signaling
1.55e-
4
GUCY1A2, GUCY1A3, PPM1L, PLCE1,
PRKAG2, PLCL1
The top three most significant pathways (right-tailed Fisher’s Exact test p-value < 0.0001) and significant protein domains (FDR p-value < 0.05) are listed.
Network analyses were stratified by gene expression directionality. Genes that displayed increased expression levels in association with one or histological
markers of intrauterine inflammation were enriched for canonical pathways and protein domains involved in inflammatory and immune processes. Genes
that displayed decreased expression levels in association with one or histological markers of intrauterine inflammation were enriched for canonical
pathways and protein domains involved early neuronal development.
https://doi.org/10.1371/journal.pone.0176953.t002
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[43,44]. In our study, we identified that genes that play a role in fetal neurodevelopment had
decreased expression levels in the cord of infants exposed to the prenatal inflammatory envi-
ronment. Broadly, these genes are associated with gap junction signaling and dopamine-
DARPP32 feedback in cAMP signaling, both of which are associated with neurodevelopment.
Gap junctions signal for crucial processes in the neonatal cerebral cortex, including neuronal
proliferation, migration, and differentiation, while dopamine signaling is known to influence
neuronal migration and dendritic growth [30,31]. Through the secondary analysis of genomic
prediction of cognitive function, a total of six genes were identified. Two of these genes that
displayed decreased expression in relation to inflammation, namely ECM2 and CRISPLD1,
have been previously indicated in neurodevelopment processes. ECM2 encodes an extracellu-
lar matrix protein of the small leucine rich glycoprotein family, which are involved in the regu-
lation of many phases of embryonic neurodevelopment [42]. CRISPLD1 has also been
reported to play a role in extracellular matrix regulation, which is known to play crucial roles
in axon growth and guidance [45]. Changes in the expression levels of genes known to play a
role in neuronal development in association with markers of prenatal inflammation contribute
to the growing body of literature that supports an association between intrauterine inflamma-
tion and cognitive impairment in later childhood [18,35].
A previous study of this ELGAN study subset extensively described the robust genomic
response that is measurable in umbilical cord tissue in relation to FIR [19]. In that study, FIR
Fig 2. Expression levels of six genes predict neurocognitive outcome at 10 years of age. Increased levels (red) of two genes that were
associated with a maker of intrauterine inflammation predicted more severe neurocognitive at 10 years of age. Decreased levels (blue) of 4
genes that were associated with a maker of intrauterine inflammation predicted more severe neurocognitive at 10 years of age. Significance
was defined as an exact p-value < 0.05 in a logistic regression model.
https://doi.org/10.1371/journal.pone.0176953.g002
Genomics and neuroimpairment
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was defined as the presence of neutrophils in both the umbilical cord and chorionic plate, and
the authors reported associations between FIR and gene expression levels of many genes,
including 434 of the 445 (97.5%) genes reported here [19]. In support of our findings, this pre-
vious analysis similarly found that genes with decreased expression in association with FIR
were enriched for roles in neurodevelopment [19]. Providing new information on pathways
that drive later life disease, our data indicate that decreased expression levels of genes related
to an inflammatory intrauterine environment are associated with adverse neurocognitive
development in children who are born prematurely.
A possible limitation of our study is our small sample size due to missing cognitive data for
21 subjects with available gene expression data. The percentage of subjects in our subset of
ELGAN infants that were lost to follow-up (21/43 = 48.8%) was much higher than that of the
larger ELGAN cohort (8%) [25]. However, previous studies suggest that loss-to-follow-up per-
centages below 60% typically are not associated with substantial bias [46]. In order to compen-
sate for our sample size, we employed exact logistic regression models, as recommended in
cases when data are sparse [47]. Despite the modest sample size, we were able to detect associa-
tions between umbilical cord genomic markers and neurocognitive function ten years after
birth.
In summary, we identified genes whose expression levels are associated with both intrauter-
ine inflammation and later-life neurocognitive impairment. Identification of genes that are
associated with adverse neurodevelopment could allow for improved surveillance for neuro-
cognitive deficits and earlier intervention for children who are at risk, which has been shown
to be an effective treatment method for children with intellectual disabilities [48]. Future
research studies could aim to identify the underlying mechanisms for the altered gene expres-
sion patterns in order to mitigate the risk for cognitive impairment in extremely low gesta-
tional age newborns exposed to intrauterine inflammation.
Supporting information
S1 Table. Processed microarray data and demographical characteristics for the n = 43
ELGAN subjects used in the present analysis.
(TXT)
S2 Table. Genes associated with markers of intrauterine inflammation. 445 genes displayed
altered expression levels in association with at least one of the following markers of intrauter-
ine inflammation: inflammation of the chorionic plate, moderate or severe chorioamnionitis,
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